Literature DB >> 9175190

Monetary reinforcement of abstinence from cocaine among mentally ill patients with cocaine dependence.

A Shaner1, L J Roberts, T A Eckman, D E Tucker, J W Tsuang, J N Wilkins, J Mintz.   

Abstract

OBJECTIVE: The study investigated whether contingency management could reduce cocaine use by patients with schizophrenia.
METHODS: An A-B-A research design, with two-month baseline, intervention, and follow-up phases, was used to study two homeless, treatment-resistant male outpatients with DSM-III-R diagnoses of schizophrenia and cocaine dependence. During the intervention phase, subjects provided daily urine specimens for testing for the cocaine metabolite benzoylecgonine (BE) and received $25 for each negative test. Concentrations of BE and metabolites of other illicit drugs were assayed twice a week to determine the amount of drug use in addition to frequency. Analysis of variance was used to compare drug use during the three study phases.
RESULTS: During the intervention, the proportion of tests positive for cocaine was lower for both subjects. Mean urinary concentrations of BE were significantly lower during the intervention than during the baseline.
CONCLUSIONS: These results suggest that modest monetary reinforcement of abstinence may decrease cocaine use among cocaine-dependent patients with schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9175190     DOI: 10.1176/ps.48.6.807

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  14 in total

1.  Weekly patterns of drug treatment attendance.

Authors:  D S Svikis; R W Pickens; W Schweitzer; E Johnson; N Haug
Journal:  Am J Public Health       Date:  1999-05       Impact factor: 9.308

Review 2.  Managing comorbid schizophrenia and substance abuse.

Authors:  R E Drake; K T Mueser
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

Review 3.  Behavioral therapies for co-occurring substance use and mood disorders.

Authors:  Kathleen M Carroll
Journal:  Biol Psychiatry       Date:  2004-11-15       Impact factor: 13.382

4.  Interdependent group contingency management for cocaine-dependent methadone maintenance patients.

Authors:  Kimberly C Kirby; Marylouise E Kerwin; Carolyn M Carpenedo; Beth J Rosenwasser; Robert S Gardner
Journal:  J Appl Behav Anal       Date:  2008

5.  Contingency management is especially efficacious in engendering long durations of abstinence in patients with sexual abuse histories.

Authors:  Nancy M Petry; Julian D Ford; Danielle Barry
Journal:  Psychol Addict Behav       Date:  2011-06

Review 6.  Using incentives to reduce substance use and other health risk behaviors among people with serious mental illness.

Authors:  Jennifer W Tidey
Journal:  Prev Med       Date:  2011-12-09       Impact factor: 4.018

7.  Better quality of life in patients offered financial incentives for taking anti-psychotic medication: Linked to improved adherence or more money?

Authors:  Katherine Moran; Stefan Priebe
Journal:  Qual Life Res       Date:  2016-02-05       Impact factor: 4.147

8.  Duration effects in contingency management treatment of methamphetamine disorders.

Authors:  John M Roll; Joy Chudzynski; Jennifer M Cameron; Donelle N Howell; Sterling McPherson
Journal:  Addict Behav       Date:  2013-04-03       Impact factor: 3.913

9.  Social Security Claims of Psychiatric Disability: Elements of Case Adjudication and the Role of Primary Care Physicians.

Authors:  Raphael J. Leo; Paula Del Regno
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-12

10.  Financial incentives to improve adherence to anti-psychotic maintenance medication in non-adherent patients - a cluster randomised controlled trial (FIAT).

Authors:  Stefan Priebe; Alexandra Burton; Deborah Ashby; Richard Ashcroft; Tom Burns; Anthony David; Sandra Eldridge; Mike Firn; Martin Knapp; Rose McCabe
Journal:  BMC Psychiatry       Date:  2009-09-28       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.